Oncimmune Holdings (GB:ONC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Oncimmune Holdings is raising a minimum of £2.0 million through a combination of placing, subscription, and retail offers to support its growth and strengthen its balance sheet. The company is converting €4.0 million of existing debt into equity, aiming to enhance commercial traction and capitalize on recent contract wins with major pharmaceutical companies. This financial strategy is expected to drive the commercialization of Oncimmune’s autoantibody profiling platform.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.
